"10.1371_journal.pone.0069524","plos one","2013-07-09T00:00:00Z","Nicholas S Kirkby; Anne K Zaiss; Paula Urquhart; Jing Jiao; Philip J Austin; Malak Al-Yamani; Martina H Lundberg; Louise S MacKenzie; Timothy D Warner; Anna Nicolaou; Harvey R Herschman; Jane A Mitchell","National Heart & Lung Institute, Imperial College London, London, United Kingdom; The William Harvey Research Institute, Barts & the London School of Medicine & Dentistry, Queen Mary University of London, London, United Kingdom; Department of Molecular and Medical Pharmacology, University of California Los Angeles, Los Angeles, California, United States of America; School of Pharmacy, University of Bradford, Bradford, United Kingdom; King Fahad Cardiac Center of King Saud University, Riyadh, Saudi Arabia; School of Life and Medical Sciences, University of Hertfordshire, Hertfordshire, United Kingdom","Conceived and designed the experiments: NSK TDW AN HRH JAM. Performed the experiments: NSK AKZ PU JJ PJA MAY MHL LSM. Analyzed the data: NSK AKZ PU JJ MAY AN. Contributed reagents/materials/analysis tools: AN HRH. Wrote the manuscript: NSK HRH JAM.","JAM and TDW have received funds from GSK and Astra Zeneca and acted as consultants and expert witnesses for Pfizer in cases where anti-inflammatory drugs, including COX-2 inhibitors have been involved. AN has received research funds and acted as consultant for projects related to supplement and drug analysis from/for Allergan, Unilever, Amarin, Equateq, GSK. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.","2013","07","Nicholas S Kirkby","NSK",12,TRUE,5,8,6,3,TRUE,TRUE,FALSE,0,NA,FALSE
